Technovation with Peter High (CIO, CTO, CDO, CXO Interviews) Moderna’s Post-COVID-19 Strategy: CIO Brad Miller AI, Innovation, and Digital Transformation in Biotech
9 snips
Sep 26, 2024 Brad Miller, CIO at Moderna who led digital transformation across R&D, manufacturing, and commercialization, discusses cloud, AI, and data platforms. He talks about shifting from COVID urgency to a diversified pipeline. He covers AI readiness, internal learning academies for prompt engineering, and lessons from finance and tech applied to biotech.
AI Snips
Chapters
Books
Transcript
Episode notes
Digital Chain Powers Drug Development
- Moderna uses cloud-native systems, data, and AI across R&D, clinical, manufacturing, and commercial to accelerate drug development.
- Technology underpins each stage from literature ingestion to manufacturing robotics and scaled commercial engagement.
Rationalize Tech After Rapid Scale
- Rationalize and converge software after a crisis-driven tech surge to reduce licensing and maintenance costs.
- Evaluate systems when you can breathe and right‑size the technology footprint to company scale.
People And Culture Make AI Work
- Success requires people, process, partnerships, and cloud-native tech, not just tooling alone.
- Moderna leverages CEO mandate, learning culture, and AI hires to apply models to medicine effectively.
